当前位置:首页 - 行情中心 - 华恒生物(688639) - 财务分析

华恒生物

(688639)

  

流通市值:71.82亿  总市值:71.82亿
流通股本:2.50亿   总股本:2.50亿

华恒生物(688639)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.49亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益260834.81万元,未分配利润113110.35万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产515282.78万元,负债254447.96万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入687,062,042.252,177,940,839.231,539,034,126.351,016,220,737.71
营业总成本632,740,817.632,017,012,228.651,382,619,720.33870,509,300.9
营业利润55,201,014.43199,316,773.49182,479,304.25163,413,402.97
利润总额54,682,602.75201,405,008.54184,110,755.53164,493,647.8
净利润49,138,959.43184,557,880.58167,996,718.7147,992,111.97
其他综合收益-15,972.35238,507.11-196,251.6588,915.74
综合收益总额49,138,959.43184,796,387.69167,800,467.05148,081,027.71
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,444,126,941.51,351,747,095.091,239,970,610.671,181,062,594.17
非流动资产合计3,708,700,831.713,637,657,788.13,464,269,466.493,311,454,582.06
资产总计5,152,827,773.214,989,404,883.194,704,240,077.164,492,517,176.23
流动负债合计1,403,507,432.861,603,530,015.652,052,065,663.022,020,127,544.63
非流动负债合计1,140,972,193.52827,496,697.52796,787,649.25638,908,731.05
负债合计2,544,479,626.382,431,026,713.172,848,853,312.272,659,036,275.68
归属于母公司股东权益合计2,616,576,699.352,564,649,586.261,858,594,150.651,836,506,921.05
股东权益合计2,608,348,146.832,558,378,170.021,855,386,764.891,833,480,900.55
负债和股东权益合计5,152,827,773.214,989,404,883.194,704,240,077.164,492,517,176.23
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计679,163,469.132,463,588,278.691,661,699,060.611,030,529,921.02
经营活动现金流出小计663,442,384.862,263,793,667.061,557,092,432.25947,556,448.92
经营活动产生的现金流量净额15,721,084.27199,794,611.63104,606,628.3682,973,472.1
投资活动现金流入小计560,0003,615,152.0413,709,894.2610,583,498
投资活动现金流出小计95,099,462.7933,710,013.72645,115,987.17453,046,520.36
投资活动产生的现金流量净额-94,539,462.7-930,094,861.68-631,406,092.91-442,463,022.36
筹资活动现金流入小计396,621,603.932,450,192,540.451,409,334,472.85833,371,849.62
筹资活动现金流出小计321,322,280.481,669,442,939.33799,377,753.45441,151,435.65
筹资活动产生的现金流量净额75,299,323.45780,749,601.12609,956,719.4392,220,413.97
汇率变动对现金及现金等价物的影响6,481,912.6612,015,901.059,654,463.178,317,616.57
现金及现金等价物净增加额2,962,857.6862,465,252.1292,811,718.0241,048,480.28
期末现金及现金等价物余额417,922,208.58414,959,350.9445,305,816.8393,542,579.06
最新报告期:2025-05-09
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
山西证券王锐,冀泳洁1.061.592.032025-05-09
中信证券李超,郭柯宇0.952.052.642025-05-07
华安证券刘天其,王强峰1.001.361.862025-05-06
长江证券马太,魏凯,王岭峰1.211.852.432025-05-02
长城证券王彤,肖亚平1.091.632.232025-04-28
TOP↑